Statement Of Changes In Equity

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7302029

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
Statement of changes in equity
Statement of changes in equity
Net assets
64,192,000,000 JPY
61,930,000,000 JPY
Changes during period
Profit (loss)
2,560,000,000 JPY
4,129,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.